Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Genet Med. 2008 May;10(5):349-52. doi: 10.1097/GIM.0b013e3181723cc8.

    Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations.

    Source

    Quest Diagnostics Nichols Institute, San Juan Capistrano, California 92690, USA. mario.x.mikula@questdiagnostics.com

    Abstract

    PURPOSE:

    To determine the carrier frequency of familial Mediterranean fever (FMF) mutations of individuals in three different US testing populations: Cystic fibrosis, Factor V Leiden, and Ashkenazi Jews.

    METHODS:

    DNA samples from 1234 anonymous samples were screened for 12 FMF mutations using a laboratory-developed test.

    RESULTS:

    Genotyping revealed carrier frequencies of 1:16, 1:46, and 1:8, respectively.

    CONCLUSION:

    MEFV mutation frequency seems to correlate positively with Mediterranean influence of the tested population and the high overall carrier rate for MEFV mutations in the Factor V Leiden testing population (1:46) suggests that the disease may be under-diagnosed in the US population or that the mutant alleles have a low penetrance.

    PMID:
    18496034
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk